Close

Karyopharm Therapeutics (KPTI) Reports In-Line Q4 EPS, Revenues Beat

Go back to Karyopharm Therapeutics (KPTI) Reports In-Line Q4 EPS, Revenues Beat
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 1.09 -0.04 (3.54%)
Previous Close $1.13    52 Week High $19.41 
Open $1.12    52 Week Low $4.83 
Day High $1.17    P/E N/A 
Day Low $1.08    EPS $-2.74 
Volume 1,591,081